Necrotizing myopathy induced by overexpression of interferon-γ in transgenic mice

A transgenic mouse model has been established in which the cytokine interferon‐γ (IFN‐γ) is overexpressed through the action of the acetylcholine receptor epsilon promoter acting at the neuromuscular junction. While originally developed as a model for the study of the pathogenesis of myasthenia grav...

Full description

Saved in:
Bibliographic Details
Published inMuscle & nerve Vol. 22; no. 2; pp. 156 - 165
Main Authors Shelton, G. Diane, Calcutt, Nigel A., Garrett, Robert S., Gu, Danling, Sarvetnick, Nora, Campana, W. Marie, Powell, Henry C.
Format Journal Article
LanguageEnglish
Published New York John Wiley & Sons, Inc 01.02.1999
Wiley
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A transgenic mouse model has been established in which the cytokine interferon‐γ (IFN‐γ) is overexpressed through the action of the acetylcholine receptor epsilon promoter acting at the neuromuscular junction. While originally developed as a model for the study of the pathogenesis of myasthenia gravis, there are important differences from both human myasthenia gravis and its animal model, experimental autoimmune myasthenia gravis. By 4 months of age there was a well‐established inflammatory, predominantly necrotizing myopathy, with marked dystrophic calcification. Dystrophic and degenerative changes in terminal axons and adjacent Schwann cells were also apparent. The acetylcholine receptor was not the primary target of the inflammatory response, since at 10 weeks of age the receptor content was not decreased and antibodies were not detected bound to the receptor. The IFNγ transgenic mouse model may provide a clinically relevant model of necrotizing myopathy for investigation of the pathological changes associated with, and presumably precipitated by, overexpression of the proinflammatory cytokine interferon‐γ on the neuromuscular junction, intramuscular nerves and myofibers. © 1999 John Wiley & Sons, Inc. Muscle Nerve 22: 156–165, 1999
Bibliography:istex:937FE75A4E96FFCD2E64225E95FA96FDB9131256
ark:/67375/WNG-WRHHD26G-D
ArticleID:MUS3
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0148-639X
1097-4598
DOI:10.1002/(SICI)1097-4598(199902)22:2<156::AID-MUS3>3.0.CO;2-U